menu ☰
menu ˟

Frequently asked questions on opioid agonist treatment for pharmaceutical opioid dependence: An evidence summary.

Creator:

Suzanne Nielsen

Subject Keywords: Pharmaceutical opioid dependence
Catalogue: Research and Evaluation
Report
Type: Report
Region: International (other)
Description:

This evidence summary from Australia comes from a program of work that aimed to build the evidence base for the treatment of pharmaceutical opioid dependence, or dependence on opioid pain medications such as oxycodone, morphine and codeine. Many of the original trials examining methadone and buprenorphine (+/- naloxone) were conducted in people dependent on heroin. In recent years new studies and revised analysis from older studies have aimed to provide information on the use of methadone and buprenorphine (+ naloxone) for those dependent on pharmaceutical opioids such as codeine, morphine and oxycodone. This document is a summary of key findings in a ‘frequently asked questions’ format.
 

Date:

01/07/2017

Rights: Public
Suggested citation:

Suzanne Nielsen. (2017) Frequently asked questions on opioid agonist treatment for pharmaceutical opioid dependence: An evidence summary. [Online]. Available from: http://www.thehealthwell.info/node/1111438 [Accessed: 22nd October 2017].

  

View your saved citations and reading lists

Contributor:

National Drugs Library
 
Click here to view all the resources gathered from this organisation's website.